Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hospital-based Cause Of Death Notification System

A National Hospital Based Mortality Notification system (HMS) was established at the beginning of 2017 in collaboration with the World Health Organization and in cooperation with the Syndicate of hospitals as an expansion of the maternal and neonatal death reporting system established in 2011. The system consists of anonymous online reporting of deaths based on an excerpt of the official death certificate form. Focal points were assigned and trained in more than 150 public and private hospitals operating in Lebanon. After reporting the information, quality checks are initiated through constant communication between the statistics department and the hospitals’ focal points. After that, the underlying cause of death is selected from the reported causes of the death.
 
 
Hospital Mortality Statistics 2025
Hospital Deaths due to COVID-19 by Week, 2020-2025 (till August 2025)​


Hospital Deaths due to COVID-19 by Month, 2020-2025 (till August 2025)​
 
 
Hospital Mortality Statistics 2024
Number of reported hospital deaths and proportional mortality due to malignant neoplasms, 2017-2024

Top Cancer Killers In Men and Women,2024
 
Hospital Mortality Statistics 2022
Top Cancer Killers in Men and Women, 2022
 
Hospital Mortality Statistics 2021
Number of reported Lebanese hospital deaths by month and age group


Number of reported hospital deaths by month and age group in Lebanon



Number of reported COVID-19 hospital deaths by month and age group


Weekly Total Hospital Deaths and COVID19 Related Deaths

 
Hospital Mortality Statistics 2020 and 2021
Weekly Total Hospital Deaths and COVID19 Related Deaths 2020​​&2021

 

 
Hospital Mortality Statistics 2020
Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group in Lebanon

Weekly Total Hospital Deaths and COVID19 Related Deaths

 
Hospital Mortality Statistics 2019
Number of reported Lebanese hospital deaths by month and age group, 2019

Number of reported hospital deaths by month and age group in Lebanon, 2019 (Updated)​
 
 
Hospital Mortality Statistics 2018
Number of reported Lebanese hospital deaths by month and age group, 2018


Number of reported hospital deaths by month and age group in Lebanon, 2018 ​
 
Hospital Mortality Statistics 2017
Number of reported Lebanese hospital deaths by month and age group, 2017


Number of reported hospital deaths by month and age group in Lebanon, 2017

Reported hospital deaths by top ICD10 chapters, 2017  
 


Top 10 cancers by ICD10 3-character code, 2017​
 


Plot of the number of the reported deaths by size and type of hospital, 2017



Five leading cancer deaths by gender, 2017
 


Top 10 leading causes of reported hospital deaths by ICD10 4-character code and gender, 2017
 
 

Proportion of reported hospital deaths by age group and gender in Lebanon, 2017 

 
 
    ...
    8
ATC Name B/G Ingredients Dosage Form Price
S01EA05 BRIMONIDINE BIOGARAN G Brimonidine tartrate - 2mg/ml 0.2% Drops solution 412,560 L.L
S01GX08 BRUNISTILL G Ketotifen - 250mcg/ml 250mcg/ml Drops solution 940,690 L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution 44,309,066 L.L
V03AB35 BRIDION B Sugammadex - 200mg/2ml 100mg/ml Injectable solution 54,230,830 L.L
V03AF03 BENDAFOLIN G Calcium folinate - 200mg/20ml 200mg/20ml Injectable solution 3,584,028 L.L
B02BD04 BENEFIX BioTech Nonacog alfa (recombinant coagulation factor IX) - 500IU 500IU Injectable powder for solution+diluent L.L
L01FF04 BAVENCIO BioTech Avelumab - 200mg/10ml 200mg/10ml Injectable concentrate for solution L.L
L01XG01 BORTEZOMIB NEAPOLIS G Bortezomib - 3.5mg 3.5mg Injectable lyophilised powder for solution L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 400mg/16ml 400mg/16ml Injectable solution L.L
L01FG01 BEVACIREL BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution L.L
C02KX01 BOSENTAN ARROW G Bosentan (monohydrate) - 62.5mg 62.5mg Tablet, film coated L.L
C02KX01 BOSENTAN ARROW G Bosentan (monohydrate) - 125mg 125mg Tablet, film coated L.L
L01EA04 BOSULIF B Bosutinib - 400mg 400mg Tablet, film coated L.L
L01EA04 BOSULIF B Bosutinib - 500mg 500mg Tablet, film coated L.L
L03AX03 BCG-MEDAC G BCG seed RIVM derived from seed 1173-P2 - 2x10⁸ to 3x10⁹ viable units Injectable powder for suspension+diluent L.L
L01FB01 BESPONSA FOR INJECTION BioTech Inotuzumab Ozogamicin - 0.9mg 0.9mg Injectable powder for suspension L.L
L01EA04 BOSULIF B Bosutinib - 100mg 100mg Tablet, film coated L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution L.L
L01AA09 BENDAVIVAL G Bendamustine HCl - 100mg 100mg Injectable concentrated powder for solution L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer L.L
    ...
    8
Sitemap
© Copyrights reserved to Ministry of Public Health 2025